Name | Lomustine |
Synonyms | cinu ceenu rb1509 cecenu nsc79037 icig1109 belustine nsc-79037 Lomustine nci-c04740 cyclohexylchloroethylnitrosourea chloroethylcyclohexylnitrosourea (cloro-2-etil)-1-cicloesil-3-nitrosourea 1-chloro-3-cyclohexyl-1-ethyl-3-nitrosourea 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosoure (chloro-2-ethyl)-1-cyclohexyl-3-nitrosourea 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea 1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-ure n-(2-chloroethyl)-n'-cyclohexyl-n-nitroso-ure |
CAS | 13010-47-4 |
EINECS | 235-859-2 |
InChI | InChI=1/C9H16ClN3O2/c1-2-12(10)9(14)13(11-15)8-6-4-3-5-7-8/h8H,2-7H2,1H3 |
InChIKey | GQYIWUVLTXOXAJ-UHFFFAOYSA-N |
Molecular Formula | C9H16ClN3O2 |
Molar Mass | 233.7 |
Density | 1.3840 (rough estimate) |
Melting Point | 88-90 |
Boling Point | 63.6°C (rough estimate) |
Flash Point | 133.2°C |
Solubility | It is soluble in chloroform, soluble in ethanol or carbon tetrachloride, slightly soluble in cyclohexane, and almost insoluble in water. |
Vapor Presure | 0.00142mmHg at 25°C |
Appearance | Yellow powder |
Color | Light orange to Yellow to Green |
Merck | 14,5564 |
pKa | 10.88±0.20(Predicted) |
Storage Condition | 2-8°C |
Refractive Index | 1.5790 (estimate) |
MDL | MFCD00012392 |
Physical and Chemical Properties | Yellow powder. Melting point 90 °c. The solubility in water, 0.1N sodium hydroxide solution, 0.1N hydrochloric acid or 10% ethanol is not all less than 0.05mg/ml; The solubility in absolute ethanol is 70 mg/ml, slightly soluble in propylene glycol. |
Hazard Symbols | T - Toxic |
Risk Codes | R45 - May cause cancer R25 - Toxic if swallowed |
Safety Description | S53 - Avoid exposure - obtain special instructions before use. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) |
UN IDs | 3249 |
WGK Germany | 3 |
RTECS | YS4900000 |
HS Code | 29299090 |
Hazard Class | 6.1(a) |
Packing Group | II |
Toxicity | LD50 in male mice (mg/kg): 51 orally; 56 i.p.; 61 s.c. (Thompson, Larson) |
This product is N-(2-chloroethyl)-N-cyclohexyl-iV-nitrosourea. The content of C9H16C1N302 shall be 98.5% to 101.5% calculated as the dry product.
The melting point of this product (General 0612) is 88~91°C.
take 0.50g of this product, add water 40ml, fully shake, filter, separate filtrate 20ml, check according to law (General rule 0801), and standard sodium chloride solution 5.0ml of the control solution should not be more concentrated (0.02%).
operation in the dark. Take this product, add methanol to dissolve and dilute to make a solution containing about 10 mg per 1ml as a test solution; Take 1ml for precision measurement, put it in a 100ml measuring flask, dilute it to the scale with methanol, as a control solution. According to the chromatographic conditions under the content determination item, the test solution and the control solution are 20 u1, respectively injected into the human liquid chromatograph, and the chromatogram is recorded to 3 times of the retention time of the main component peak. If there are impurity peaks in the chromatogram of the test solution, the sum of each impurity peak area shall not be greater than the main peak area of the control solution (1.0%).
take this product, put it in a phosphorus pentoxide dryer, and dry it under reduced pressure at 60°C to a constant weight, and the weight loss shall not exceed 0.5% (General rule 0831).
operation in the dark. Determined by high performance liquid chromatography (General 0512).
silica gel bonded with eighteen alkyl silane was used as the filler; Methanol-water (70:30) was used as the mobile phase; The detection wavelength was 230nm. The number of theoretical plates is not less than 3000 based on the Lomustine peak.
take this product, precision weighing, plus mobile phase dissolution and dilution of children made from each lml containing about 0. The lmg solution was used as the test solution, and 20ul of the solution was accurately measured. The liquid chromatograph was injected and the chromatogram was recorded. According to the external standard method to calculate the peak area, that is.
antineoplastic agents.
shading, sealing, storage in cold place.
This product contains Lomustine (C9H16ClN302) should be 90.0% to 110.0% of the label amount.
The content of this product is light yellow crystal or crystalline powder.
The contents of this product were taken, and the same results were obtained according to the tests (1), (2) and (4) under the item of Lomustine.
operation in the dark. Take the contents under the item of difference in loading, mix well, accurately weigh appropriate amount, add mobile phase to dissolve lomustine and quantitatively dilute it to make it contain about 0 lomustine per 1 ml. 1 mg of the solution was filtered and used as a test solution. Obtained according to the method under the item of content determination of Lomustine.
Same as lomustine.
(l)40mg (2)100mg